PubMed COVID-19 Clinical Care
3861 - 3870 of 5506 results found
Covid-19: UK's pandemic inquiry prepares to hear from witnesses
Description
No abstract
Correlation of bone density measured on CT chest with the severity of COVID-19 infection: A retrospective study
Description
CONCLUSION: The BMD had no prognostic advantage, and the PSS was the significant factor that could have predicted the outcome.
Coinfection with SARS-CoV-2 and Cytomegalovirus in a Patient with Mild COVID-19
Description
Persistent fever due to coronavirus disease 2019 (COVID-19) is a considerable issue for patients and physicians that requires a broad differential diagnosis and evaluation of complications. Coinfections with severe acute respiratory syndrome
Cognitive impairment in long-COVID and its association with persistent dysregulation in inflammatory markers
Description
CONCLUSION: Though we identified several sociodemographic characteristics that might protect against cognitive impairment following SARS-CoV-2 infection, our data do not support a prominent role for clinical status (both during acute and long-stage
Clinical importance of thoracal lymphadenopathy in COVID-19
Description
CONCLUSIONS: Thoracal lymphadenopathy comprising cumulative size and affected levels derived from CT images is associated with 30-day mortality in patients with COVID-19. COVID-19 patients presenting with thoracic lymphadenopathy should be considered
Communicating with ethnic minorities during COVID-19: An experimental test of the effect of self-, ingroup-, and intergroup-focused messages
Description
Developing messaging to encourage minorities to adhere to health recommendations has been a complex task for governments worldwide during the COVID-19 crisis. Here, we propose and tests a new typology of messages among minorities that can be used to
Comorbidity Patterns and Mortality Among Hospitalized Patients with Psychiatric Disorders and COVID-19
Description
CONCLUSIONS: All psychiatric and non-psychiatric conditions may be associated with increased mortality in patients with psychiatric disorders and COVID-19. The lower risk of death among patients with mood disorders might be in line with the potential
Changes in SARS-CoV-2 seroprevalence and population immunity in Finland, 2020-2022
Description
Studying the prevalence of SARS-CoV-2 specific antibodies (seroprevalence) allows for assessing the impact of epidemic containment measures and vaccinations and estimating the number of infections regardless of viral testing. We assessed antibody
Covid-19: Metformin reduces the risk of developing long term symptoms by 40%, study finds
Description
No abstract
